Merck, the Fda and the Vioxx Recall Essay

Do you believe that Merck acted in a socially responsible and ethical manner with regard to Vioxx? Why or why not? In your answer, please address the company’s drug development and testing, marketing and advertising, relationships with government regulators and policymakers, and handling of the recall. No, Merck didn’t act in a corporate social responsibility in regards to Vioxx. Corporate social responsibility means that a corporation should act in a way that enhances society and its inhabitants…

Merck and the Recall of Vioxx Florence N. Wandera MGT 600 – Corporate Responsibility & Bus Law Merck and the Recall of Vioxx Case Summary Merck & Co. Inc. is a global research-driven pharmaceutical company that develops, manufactures and markets a broad range of human health products. One such product is Vioxx, developed in 1994 and approved on May 21, 1999 by the United States Food and Drug Administration (FDA) for the treatment of pain, inflammation, and stiffness caused by arthritis…

Background on the Case Study For years, Merck had been a successful and reputable pharmaceutical company that was known for its high-quality products and world-class research centres, and was often regarded in a good light compared to its less favourable competitors. However, all this fell apart in the early 2000s with the recall of the company’s “blockbuster” drug “Viroxx.” It was meant to act similar to ibuprofen in ways that it cured osteoarthritis and acute pain, but was withdrawn in 2004…

Running head: CASE STUDY: MERCK & COMPANY: THE VIOXX RECALL Merck & Company: The Vioxx Recall Albert Balogun California Baptist University BUS 520A: Managerial Ethics Jim Bishop, PhD June 30, 2010 Merck & Company: The Vioxx Recall The issues involved in Merck, a pharmaceutical manufacturing company’s recall of one its products, Vioxx, is the effect of direct-to-consumer (DTC) advertising of prescription drug on the society public…

Evaluating Merck & Co., Inc vs. Pfizer, Inc. Amy Lan Lan Liu Connor Buestad Raghul Subramanian Natalia Cosa ACCT 831 March 16, 2011 Table of Contents: Part 1: History, Background and Core Business …...................................................................2 a. Merck & Co., Inc. ….............................................................................................................. 2 b. Pfizer…

Vioxx/Merck Summary The painkiller Vioxx was introduced in 1999 by Merck & Co. It has been used by over 20 million Americans since it was put on the market. Vioxx remained on the market for approximately five years without adequate warnings about its risks. In September of 2004, Merck took Vioxx off the market after a study revealed that it doubled the risk of heart attack or stroke for patients that used it for more than 18 months. Although Merck claimed that they had no idea of these possibly…

Introduction Since its humble beginning as a small drugstore, Merck has placed a large amount of importance on improving the health and well-being of its customers. As drug patents expire and genetic forms of their top products become available, Merck’s strategy is to do the unexpected; instead of raising the price of their older products in favor of patent protected new drugs, Merck focuses on reducing their cost in order to better compete with their generic counterparts. Additionally, Merck’s…

Question 1 Merck was known as an ethical and socially responsible drug manufacturer. Back in 1950, George W. Merck, CEO, said, “We try never to forget that medicine is for the people. It is not for the profits” (Lawrence & Weber, 2014). Merck was also known for research and innovation in developing new drugs as well as their philanthropic efforts. This was a company that had built its success on a solid reputation of being an ethical and socially responsible organization. The Vioxx case is evidence…

Merck & Co. Executive Summary Case Study Goal The goal of this case study is to examine the current operations of Merck & Co. Inc. and determine areas of potential concern, evaluate the effectiveness of the current business model, and propose a plan of action to grow Merck & Co. Inc. to be the largest pharmaceutical company in the world. Methods of Analysis This case study will strive to identify areas of concern and opportunity, offer solutions, and make projections based upon historic data…

Central Problem In the Merck, the FDA, and the Vioxx Recall case study, the question as to whether or not Merck conducted itself in a socially responsible and ethical manner with regard to Vioxx is the central problem we will examine in this case. Many argue that the sole problem lies within the pharmaceutical company Merck and Co., Inc., and while that may in fact be the case, other parties such as the Food and Drug Administration (FDA) can be held responsible as well. Merck a “research driven” pharmaceutical…